• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes.分析 2 型糖尿病患者尿白蛋白排泄率(UAER)与肾小球滤过率(eGFR)的相关性及 eGFR 下降的危险因素。
BMC Endocr Disord. 2024 Oct 28;24(1):228. doi: 10.1186/s12902-024-01761-8.
2
Correlation of serum thyrotropin and thyroid hormone levels with diabetic kidney disease: a cross-sectional study.血清促甲状腺激素和甲状腺激素水平与糖尿病肾病的相关性:一项横断面研究。
BMC Endocr Disord. 2024 Aug 30;24(1):170. doi: 10.1186/s12902-024-01699-x.
3
Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients.2型糖尿病患者中尿、肾小球及肾小管标志物与糖尿病肾病发生的相关性。
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22191. Epub 2017 Feb 25.
4
Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).原发性高血压 2 型糖尿病患者中糖尿病肾病的患病率:来自韩国高血压流行病学研究 III(KEY III 研究)的数据。
Nephrol Dial Transplant. 2011 Oct;26(10):3249-55. doi: 10.1093/ndt/gfr011. Epub 2011 Mar 3.
5
Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease.利拉鲁肽与 2 型糖尿病伴糖尿病肾病患者的肾脏结局。
Am J Nephrol. 2020;51(10):806-814. doi: 10.1159/000510255. Epub 2020 Sep 23.
6
Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.2型糖尿病患者血清β-促胰岛素分泌素水平升高与尿白蛋白排泄及肾功能相关。
Cardiovasc Diabetol. 2016 Jan 7;15:3. doi: 10.1186/s12933-015-0326-9.
7
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.2 型糖尿病儿童和青少年的胰岛素敏感性与糖尿病肾脏疾病:来自 TODAY 临床试验数据的观察性分析。
Am J Kidney Dis. 2018 Jan;71(1):65-74. doi: 10.1053/j.ajkd.2017.07.015. Epub 2017 Nov 20.
8
The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes.在2型糖尿病患者中,估计肾小球滤过率与亚临床动脉粥样硬化相关,且独立于蛋白尿。
Int Angiol. 2013 Oct;32(5):532-9.
9
Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.肾小球滤过率较高的2型糖尿病患者肾功能迅速下降,随后肾小球滤过率受损:日本糖尿病并发症研究。
J Diabetes Complications. 2017 Feb;31(2):473-478. doi: 10.1016/j.jdiacomp.2016.06.020. Epub 2016 Jun 29.
10
Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study.老年 2 型糖尿病患者骨转换标志物与肾脏疾病的关系:一项横断面研究。
BMC Endocr Disord. 2024 Sep 6;24(1):179. doi: 10.1186/s12902-024-01698-y.

本文引用的文献

1
Clinical trial designs of emerging therapies for diabetic kidney disease (DKD).新兴疗法治疗糖尿病肾病(DKD)的临床试验设计。
Postgrad Med. 2024 Aug;136(6):585-593. doi: 10.1080/00325481.2024.2377529. Epub 2024 Jul 24.
2
Effects of genetically proxied statins on diabetic nephropathy and retinopathy: a Mendelian randomization study.遗传邻近他汀类药物对糖尿病肾病和视网膜病变的影响:一项孟德尔随机研究。
Sci Rep. 2024 Jul 23;14(1):16885. doi: 10.1038/s41598-024-67800-5.
3
Huajuxiaoji Formula Alleviates Phenyl Sulfate-Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis.化浊消积方通过抑制 NLRP3 炎性小体激活和焦亡缓解对苯磺酸酯诱导的糖尿病肾病。
J Diabetes Res. 2024 Jul 15;2024:8772009. doi: 10.1155/2024/8772009. eCollection 2024.
4
Racial and ethnic representation in peripheral artery disease randomized clinical trials.外周动脉疾病随机临床试验中的种族和民族代表性。
Ann Vasc Surg. 2024 Nov;108:355-364. doi: 10.1016/j.avsg.2024.05.034. Epub 2024 Jul 14.
5
Nephrologist follow-up care for the acute kidney injury-chronic kidney disease continuum and clinical outcomes: A systematic review and meta-analysis.肾脏病学家对急性肾损伤-慢性肾脏病连续体的随访护理和临床结局:系统评价和荟萃分析。
J Chin Med Assoc. 2024 Mar 1;87(3):280-286. doi: 10.1097/JCMA.0000000000001052. Epub 2024 Jan 29.
6
The construction of a TCM knowledge graph and application of potential knowledge discovery in diabetic kidney disease by integrating diagnosis and treatment guidelines and real-world clinical data.通过整合糖尿病肾病的诊疗指南和真实世界临床数据构建中医知识图谱并应用于潜在知识发现。
Front Pharmacol. 2023 May 31;14:1147677. doi: 10.3389/fphar.2023.1147677. eCollection 2023.
7
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2020慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019.
8
Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP.糖尿病肾病中 TRIM13 的 DNA 甲基化改变通过促进 CHOP 的泛素化来抑制系膜胶原合成。
EBioMedicine. 2020 Jan;51:102582. doi: 10.1016/j.ebiom.2019.11.043. Epub 2020 Jan 2.
9
Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.糖尿病肾病转化研究(TRIDENT)的原理与设计
Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020.
10
Luteolin Attenuates Diabetic Nephropathy through Suppressing Inflammatory Response and Oxidative Stress by Inhibiting STAT3 Pathway.木犀草素通过抑制信号转导和转录激活因子3(STAT3)通路抑制炎症反应和氧化应激来减轻糖尿病肾病。
Exp Clin Endocrinol Diabetes. 2021 Oct;129(10):729-739. doi: 10.1055/a-0998-7985. Epub 2020 Jan 2.

分析 2 型糖尿病患者尿白蛋白排泄率(UAER)与肾小球滤过率(eGFR)的相关性及 eGFR 下降的危险因素。

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes.

机构信息

Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, No. 8, Workers' Stadium South Road, Hujialou Street, Chaoyang District, Beijing, 100020, China.

出版信息

BMC Endocr Disord. 2024 Oct 28;24(1):228. doi: 10.1186/s12902-024-01761-8.

DOI:10.1186/s12902-024-01761-8
PMID:39468537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11514529/
Abstract

OBJECTIVE

To analyse the correlation between urinary albumin excretion rate (UAER) and estimated glomerular filtration rate (eGFR) and the risk factors for reducing eGFR in patients with type 2 diabetes mellitus (T2DM).

METHODS

A total of 431 T2DM patients admitted between January 2019 and March 2020 were selected and divided into two groups according to eGFR level. Comparing the differences between baseline data and clinical indicators, multivariate logistic regression was used to analyse the risk factors of eGFR reduction and to analyse the association between UAER and eGFR.

RESULTS

In total, 167 patients were included in the study group and 264 patients were included in the conventional group. The study group participants were older, had longer diabetes duration, and had higher fatty liver, peripheral vascular disease (PVD), hypertension prevalence, and mean body mass index (P < 0.05). The levels of various indicators were lower than those of the conventional group (P < 0. 05). Additionally, PVD, nocturnal systolic blood pressure, fatty liver, and beta-2-microglobulin (β 2-MG) were independent risk factors for eGFR decline, with high density lipoprotein (HDL) and fasting C-peptide (CP) as protective factors. There was no obvious correlation between UAER and eGFR.

CONCLUSION

Peripheral vascular disease, systolic blood pressure, fatty liver, and beta-2-microglobulin are risk factors for decreased eGFR levels in patients with T2DM, which should be applied for control DKD. HDL and fasting CP have important effects on maintaining eGFR, and blood pressure and fasting CP can be used as new targets for subsequent diabetic kidney disease treatment.

摘要

目的

分析 2 型糖尿病(T2DM)患者尿白蛋白排泄率(UAER)与估算肾小球滤过率(eGFR)的相关性及 eGFR 降低的危险因素。

方法

选取 2019 年 1 月至 2020 年 3 月期间收治的 431 例 T2DM 患者,根据 eGFR 水平分为两组。比较两组基线资料及临床指标的差异,采用多因素 logistic 回归分析 eGFR 降低的危险因素,并分析 UAER 与 eGFR 的相关性。

结果

共纳入研究组 167 例,常规组 264 例。研究组患者年龄较大,糖尿病病程较长,且脂肪肝、外周血管疾病(PVD)、高血压患病率、平均体质量指数较高(P<0.05)。各项指标水平均低于常规组(P<0.05)。此外,PVD、夜间收缩压、脂肪肝、β 2-微球蛋白(β 2-MG)是 eGFR 下降的独立危险因素,高密度脂蛋白(HDL)和空腹 C 肽(CP)是保护因素。UAER 与 eGFR 无明显相关性。

结论

PVD、收缩压、脂肪肝和β 2-MG 是 T2DM 患者 eGFR 降低的危险因素,应积极控制 DKD。HDL 和空腹 CP 对维持 eGFR 有重要作用,血压和空腹 CP 可作为后续糖尿病肾病治疗的新靶点。